Huang et al. suggested that Beclin-1 induced apoptosis via Bcl-xL and Bcl-2 binding, consequently releasing BCL2-antagonist/killer (Bak) and Bax, which further activates caspases-3/-9 in glioma cells [89]. Here, BCL2 is linked to central nervous system cancer.